## OMC: Omnicom Group Inc. - XLC: Communication Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.2% in upper entry zone (4.0-10.0%), top 4% cross-sectional ranking. Short-term MRS_5 (0.7%) confirms momentum alignment. Momentum building (+0.6% 5-day). Outperforming sector by 7.5%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($77.45)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Omnicom Health merges DDB Health, The Purpose Group to create Remedy Edge**
- Source: Medical Marketing and Media | 20251217T220336 | Somewhat-Bullish | Relevance: 100%
- Omnicom Health has merged DDB Health and The Purpose Group to form a new full-service agency named Remedy Edge. This new entity will combine DDB Health’s HCP marketing expertise with The Purpose Group’s patient-centric knowledge. Remedy Edge will be led by Jennie Fischette, former CEO of DDB Health, and Michael Schreiber, former managing partner and chief creative officer of DDB Health.

**2. Omnicom Media Digital Gets AUNZ CEO: TikTok's Andrew Cambridge**
- Source: Little Black Book | LBBOnline | 20251216T000829 | Bullish | Relevance: 100%
- Omnicom has appointed Andrew Cambridge, formerly TikTok's AUNZ head of agency, as CEO of Omnicom Media Digital across Australia and New Zealand. This move follows his five-year tenure at TikTok and marks his return to media agencies, reuniting with former colleague Daniel Klug. The appointment is part of a broader re-organization within Omnicom following its acquisition of IPG Mediabrands.

**3. BBVA selects Omnicom as its global partner for its creative and media agency model**
- Source: BBVA | 20251217T171126 | Bullish | Relevance: 100%
- BBVA has chosen Omnicom as its global partner for a new creative and media agency model, termed ‘Casa BBVA’. This partnership aims to integrate strategy, creativity, media, and data management under a global vision with local execution across all countries where BBVA operates. The collaboration will strengthen brand consistency, enhance client experience, and drive commercial transformation focused on personalization and leveraging AI.

**4. Ex-Dividend Reminder: Turning Point Brands, Omnicom Group and Hamilton Lane**
- Source: Nasdaq | 20251217T150811 | Neutral | Relevance: 100%
- Turning Point Brands Inc (TPB), Omnicom Group, Inc. (OMC), and Hamilton Lane Incorporated - Class A (HLNE) are all set to trade ex-dividend on December 19, 2025. Investors should anticipate a slight dip in their share prices, assuming all other factors remain constant, reflecting the upcoming dividend payments. The article provides the dividend amounts, payment dates, and estimated annualized yields for each company.

**5. Omnicom (OMC) Receives Equal Weight Rating from Morgan Stanley**
- Source: GuruFocus | 20251216T103123 | Neutral | Relevance: 100%
- Morgan Stanley has assigned Omnicom (OMC) an "Equal Weight" rating with an $88 price target, indicating a balanced outlook for the stock. While the company's deal integrations offer growth potential, they also present inherent risks. Omnicom's financial health, characterized by stable growth and efficiency, is balanced by moderate liquidity and a reliance on debt financing.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | UBS | $108 | $99 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 13 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (-0.4%)
- Blackrock Inc.: 10.7% (+0.7%)
- State Street Corpora: 8.7% (+15.8%)
- JPMORGAN CHASE & CO: 8.4% (+160.9%)
- Massachusetts Financ: 3.9% (-5.5%)

### Key Risks

1. Valuation stretched: PEG 16.3x requires aggressive growth execution.
2. Elevated short interest (10.3%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 16.28 signals overvaluation risk, limited margin of safety. Forward P/E 8.4x attractive for 15% earnings growth. Quality metrics strong (ROE 27%). Analyst sentiment positive (1 raises, avg +9%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.9B |
| Beta | 0.76 |
| 52W Range | $68.37 - $89.81 |
| Short Interest | 10.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 16.28 |
| Forward P/E | 8.4 |
| Current P/E | 9.6 |
| YoY Growth | 15.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+0.6% over 5 days). Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 0.7% confirms short-term momentum alignment. AM_20 at 8.5% shows strong absolute momentum above own 20MA. Outperforming sector by 7.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.12), confirming momentum. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.22% (CS: 96) | Strong |
| RSI_14 | 67.6 | Neutral |
| MACD Histogram | 1.12 | Bullish |
| vs SMA20 | 1.085x | Above |
| vs SMA50 | 1.080x | Above |
| vs SMA200 | 1.080x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $81.67
- **Stop Loss:** $77.45 (5.2% risk)
- **Target:** $88.00 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 270
- **Position Value:** $22,050.90
- **Portfolio %:** 22.05%
- **Risk Dollars:** $1,140.00
- **Risk Per Trade:** 1.14%
- **Modifiers:** L1 95% | L2 120% | Combined 1.14x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-10 (Est: $2.63)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.17 | $2.24 | +3.1% |
| 2025Q2 | $2.03 | $2.05 | +0.8% |
| 2025Q1 | $1.66 | $1.70 | +2.3% |
| 2024Q4 | $2.39 | $2.41 | +0.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*